scholarly article | Q13442814 |
P356 | DOI | 10.1006/ABBI.2000.2244 |
P698 | PubMed publication ID | 11370840 |
P50 | author | José María Gutiérrez | Q42425503 |
Richard John Ward | Q42576744 | ||
P2093 | author name string | R K Arni | |
A M Soares | |||
J R Giglio | |||
S H Andrião-Escarso | |||
L Rodrigues-Simioni | |||
R K Bortoleto | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
snake venom | Q424200 | ||
Bothrops pirajai | Q2911793 | ||
P304 | page(s) | 188-196 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Archives of Biochemistry and Biophysics | Q635818 |
P1476 | title | Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom | |
P478 | volume | 387 |
Q38292301 | Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis |
Q39962923 | Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies |
Q44672908 | Alkylation of myotoxic phospholipases A2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production |
Q38256053 | Antibacterial activity of an acidic phospholipase A2 (NN-XIb-PLA2) from the venom of Naja naja (Indian cobra) |
Q41186048 | Antibacterial potential of a basic phospholipase A2 (VRV-PL-VIIIa) from Daboia russelii pulchella (Russell's viper) venom |
Q33660928 | Biochemical and functional characterization of Parawixia bistriata spider venom with potential proteolytic and larvicidal activities |
Q39181882 | Chemical modifications of PhTX-I myotoxin from Porthidium hyoprora snake venom: effects on structural, enzymatic, and pharmacological properties |
Q40542170 | Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom |
Q42000371 | Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms |
Q43167411 | Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom |
Q43680853 | Effects of chemical modifications of crotoxin B, the phospholipase A(2) subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities |
Q53863006 | Functional expression and characterization of a recombinant phospholipase A2 from sea snake Lapemis hardwickii as a soluble protein in E. coli |
Q34394681 | Harpalycin 2 inhibits the enzymatic and platelet aggregation activities of PrTX-III, a D49 phospholipase A2 from Bothrops pirajai venom. |
Q52842163 | Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract. |
Q60696810 | Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2 |
Q33185785 | Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). |
Q33340860 | Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga |
Q41866801 | Molecular evolution and structure-function relationships of crotoxin-like and asparagine-6-containing phospholipases A2 in pit viper venoms |
Q44485356 | Myotoxicity induced by an acidic Asp-49 phospholipase A(2) isolated from Lachesis muta snake venom. Comparison with lysophosphatidylcholine |
Q34459969 | Ophidian envenomation strategies and the role of purines |
Q34584995 | PhTX-II a basic myotoxic phospholipase A₂ from Porthidium hyoprora snake venom, pharmacological characterization and amino acid sequence by mass spectrometry |
Q42018281 | Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells. |
Q48286322 | Purification and partial characterization of an anticoagulant PLA2 from the venom of Indian Daboia russelii that induces inflammation through upregulation of proinflammatory mediators. |
Q41813405 | Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved? |
Q27650993 | Structural Characterization of Myotoxic Ecarpholin S From Echis carinatus Venom |
Q44094218 | Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom. |
Q31058316 | Structural and functional characterization of basic PLA2 isolated from Crotalus durissus terrificus venom. |
Q40442267 | Structural and functional evidence for membrane docking and disruption sites on phospholipase A2-like proteins revealed by complexation with the inhibitor suramin. |
Q39434054 | Sulfonyl fluorides as privileged warheads in chemical biology |
Q41141374 | The Antimicrobial Activity of an Acidic Phospholipase A₂ (NN-XIa-PLA₂) from the Venom of Naja naja naja (Indian Cobra). |
Q42156718 | Topology of the substrate-binding site of a Lys49-phospholipase A2 influences Ca2+-independent membrane-damaging activity. |
Q35097174 | Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus) |
Q33558677 | cDNA and deduced primary structure of basic phospholipase A2 with neurotoxic activity from the venom secretion of the Crotalus durissus collilineatus rattlesnake. |
Search more.